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Description of Herd-Outbreaks Using Killed PRRSV Vaccine  with an Attempt to 
Boost Immune Response 
Gaurav Rawal, DVM; Christopher Rademacher, DVM; Daniel Linhares, DVM, MBA, PhD 
Objective 
The objective of this study was to describe demographic characteristics, management practices, and 
live PRRSV exposure methods of herd-outbreaks that adopted a killed vaccine protocol.  
Materials and Methods 
A retrospective observational study was conducted, following 38 PRRSV herd-outbreaks from 19 
herds  reporting vaccination with KV (MJPRRS®). A herd-outbreak was defined as a wild-type 
PRRSV introduction in a breeding herd, as reported by veterinarians. A survey was used to record 
key demographic information including herd size (number of breeding sows in the inventory), 
geographic region, location of gilt  acclimation site (offsite or onsite), duration of herd closure (in 
weeks), prior PRRS status before an outbreak (stable or unstable), frequency of weaning events/week 
(1 and 2 or 3+), PRRSV exposure combinations in breeding sows and gilts, number of doses (before 
and after an outbreak)/year and RFLP strains. Moreover, weekly productivity data was gathered.  
Outbreaks were considered “clinical herd-outbreaks” as defined by American Association of Swine 
Veterinarians (AASV) when there was evidence of PRRS-associated changes in productivity such as 
significant decrease in weaned pigs or spike in the number of weekly aborts. Time to baseline 
production (TTBP), and total loss/ thousand sows (TL/1000 sows) were reported for clinical herd-
outbreaks, as previously established (Linhares  et al., 2014). Herd-outbreaks were censored if dropped 
from the study between enrollment and reaching TTBP or at 52 weeks if not having reached TTBP.  
Multivariate analysis was done only for the clinical herd-outbreaks. More specifically, survival 
analyses were used to compare TTBP and TL/1000 sows between different exposure combinations in 
gilts and sows. The time-to-event (Kaplan-Meier survival analysis) for TTBP, and Kruskal-Wallis for 
TL were done. Statistical analyses were performed with SAS version 9.4 (SAS Institute Inc., Cary, 
North Carolina). 
Results 
There were 6 different exposure combinations of KV in gilts and 4 different exposure combinations of 
KV in sows with 0–4 numbers of KV doses/year having been delivered both before and after an 
outbreak.  
The exposure combinations in gilts were (a) natural virus only (n = 2), (b) live-resident virus 
inoculation (LVI) and KV (n = 12), (c) LVI only (n = 2), (d) MLV and KV (n = 7), (e) MLV and LVI (n 
= 3), (f) KV and feedback materials (tissues, serum, fecal materials, or other biologically derived 
products) (n = 1); and the exposure combinations in sows were (a) KV only (n = 16), (b) KV and MLV 
(n = 8), (c) KV, MLV, and feedback (n = 2), (d) KV and feedback (n = 1).  
Regarding gilt exposure protocols, 45% of the clinical herd-outbreaks used an LVI + KV 
combination, and, regarding sow exposure, 59% of the clinical herd-outbreaks used KV only. The 
exposure combination of MLV + KV in gilts and the exposure combination of KV + feedback material 
in sows had a median TTBP and TL of  
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zero. The herd-outbreaks using KV only as exposure after an outbreak in sows had a median TTBP of  
13.5 weeks and median TL/1000 sows of 1305, and the herd-outbreaks using LVI + KV as an exposure 
in  gilts had a median TTBP of 13.5 weeks and median TL/1000 sows of 971. Of the clinical herd-
outbreaks,  89% used 3 KV doses/year before the outbreak with median TTBP of 13 weeks, and 67% 
used 3 KV doses/ year after the outbreak with median TTBP of 6.5 weeks. When comparing herd 
closure protocols, 78% of the herd-outbreaks utilizing KV implemented no herd closure. The herd-
outbreaks implementing herd closure had a TTBP 5 weeks shorter than herd-outbreaks not 
implementing herd closure. The median TL/1000 sows was also significantly smaller in herd-
outbreaks implementing herd closure, compared to those that did not. 
Table 1. Demographic characteristics of the clinical herd-outbreaks. 
 
Herd size (mean ± SE) ______________________________ 2918 ± 1198 sows 
Weaning frequency ________________________________ 1 and 2/week: 10 (37%) 
   3+/week: 17 (63%) 
Gilt acclimation site ________________________________ GDU offsite: 11 (41%) 
   GDU onsite: 16 (59%) 
Prior PRRS status __________________________________ PRRS unstable: 3 (11%) 
   PRRS stable: 24 (89%) 
U.S. region ________________________________________ Midwest: 27 (100%) 
   Southeast: 0 (0%) 
 
  
Table 2. Exposure characteristics of the clinical herd-outbreaks. 
  Median TTBP (in weeks)  Median TL/1000 Sows   
Characteristics  (25th and 75th percentile)  (25th and 75th percentile) 
Exposure combinations (gilts)  
Natural virus (n = 2, 7%)  
  
21.5 (20, 23)  1182 (1035, 1330) 
LVI + KV (n = 12, 45%)  13.5 (0,15.5)  971 (0, 1962.5) 
LVI (n = 2, 7%)  16.5 (13, 20)  0 (0,0) 
MLV + KV (n = 7, 26%)  0 (0, 13)  0 (0, 3696) 
MLV + LVI (n = 3, 11%)  13 (0, 27)  1451 (0, 7189) 
KV + Feedback (n = 1, 4%)  0 (0, 0)  0 (0, 0) 
Exposure combinations (sows)  
KV (n = 16, 59%)  
  
13.5 (0, 18.5)  1305 (0, 2028) 
KV + MLV (n = 8, 30%)  0 (0, 10)  0 (0, 517.5) 
KV + MLV + Feedback (n = 2, 7%)  15.5 (13, 18)  3978 (3696, 4260) 
KV + Feedback (n = 1, 4%)  0 (0, 0)  0 (0, 0) 
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Table 3. Management practices of clinical herd-outbreaks.  
 
  Median TTBP (in weeks)  Median TL/ 1000 Sows    
Characteristics  (25th and 75th percentile)   (25th and 75th percentile) 
    
 
Number of KV doses/year (before outbrea 
0 (n = 2, 7%)  
k)  
21.5 (20, 23)  
  
1183 (1035, 1330) 
1 (n = 1, 4%)  0 (0, 0)  0 (0, 0) 
3 (n = 24, 89%)  13 (0, 15.5)  391 (0, 2028) 
Number of KV doses /year (after outbreak) 
2 (n = 1, 4%)  
  
0 (0, 0)  
  
0 (0, 0) 
3 (n = 18, 67%)  6.5 (0, 18)  0 (0, 1391) 
4 (n = 8, 29%)  14 (6.5, 19)  1816 (580, 2559) 
Herd closure days  
None (n = 21, 78%)  
  
13 (0, 17)  782 (0, 3090)  
≥ 42 days (n = 6, 22%)  7 (0, 20)  518 (0, 1330) 
  
Figure 1. Distribution of RFLP strains in KV clinical herd outbreaks. 
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Conclusion 
This study described for the first-time herd characteristics, management practices, and live PRRSV 
exposure methods associated with use of KV for PRRS control in infected breeding herds. 
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